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Antibody independent crescentic glomerulonephritis in chain defi-
cient mice. The hypothesis that crescent formation in glomerulonephritis
(GN) is a delayed type hypersensitivity (DTH)-like lesion, not dependent
on a humoral immune response, was addressed using mice with deletion of
the r immunoglobulin heavy chain gene (p. chain deficient mice). Ho-
mozygous p. chain deficient mice do not develop mature B cells or produce
immunoglobulin, but have intact cell mediated immunity. GN was induced
in sensitized mice by a subnephritogenic dose of sheep anti-mouse GBM
globulin. Heterozygous mice (p. chain +7—) demonstrated normal anti-
body and DTH responses to sheep globulin and developed a proliferative
GN with proteinuria (6.4 1.4 mg124 hr), renal impairment (serum
creatinine 32.6 3.3 p.mol/liter) and crescents in 33 2.4% of glomeruli,
when this antigen was planted in their glomeruli. This lesion was demon-
strated to be T cell dependent by in vivo T cell depletion. Homozygous p.
chain deficient mice (—I—) also developed proliferative GN, histologically
indistinguishable from +7— mice. Proteinuria (3.8 1.0 mg/24 hr), renal
impairment (serum creatinine 24.5 3.4 p.mol/liter) and crescent forma-
tion (29 2% of glomeruli) were no different from =7— mice. Mouse
immunoglobulin was absent in their serum and glomeruli, however,
cutaneous DTH to sheep globulin was identical to heterozygous mice.
These results demonstrate that glomerular crescent formation and injury
can occur independent of a humoral immune response to planted glomer-
ular antigen and without glomerular deposition of autologous antibody.
This strongly supports the hypothesis that crescent formation is a mani-
festation of DTH.
Many patients develop crescentic glomeruionephritis (GN) in
the absence of detectable giomerular deposition of immunoglob-
ulin in their renal biopsies [1], suggesting that glomerular crescent
formation is not dependent on the humoral arm of the immune
response. The prominent participation of T cells, macrophages
and fibrin in human [21 and experimental [3] crescentic GN
suggests a pivotal role for cellular immunity in the development of
crescents. Depletion of T helper cells with specific monoclonal
antibodies during the effector phase of experimental anti-glomer-
ular basement membrane (anti-GBM) induced GN in rats [3]
significantly attenuates development of crescents, further suggest-
ing a key role for T cells in crescentie GN, In these T cell depleted
rats, inhibition of crescentic GN is observed without detectable
attenuation of the humoral immune response to the disease
initiating antigen.
The development of technology to delete genes in the germ line
Received for publication June 3, 1996
and in revised form September 3, 1996
Accepted for publication September 3, 1996
© 1997 by the International Society of Nephrology
of mice has allowed development of animals with a variety of
selective genetic deficiencies, including selective and specific
immunological lesions. The p. chain knock-out mouse was created
by a gene-targeted knock out of the trans-membrane portion of
the 1gM molecule, leading to a failure of B cell precursors to
progress beyond the early pre-B stage [4]. These mice fail to
develop mature B cells and cannot produce immunoglobulin.
However, their T cell function is normal [5] and they develop
normal cellular immune responses including cutaneous DTH. In
heterozygous (p. chain +7—) mice, B cell precursors develop
normally into B cells and plasma cells and their immunoglobulin
production is normal, consistent with the view that in normal B
cell development, productive rearrangement of a single single
heavy chain gene results in allelic exclusion at this locus.
A planted antigen model of GN (anti-GBM GN), which results
in crescentic disease in normal mice, was used to determine the
contribution of humoral immunity to the development of glomer-
ular crescents, This question was addressed by comparing the
development of this disease in antibody deficient mice (p. chain
—I—) with its development in their heterozygous littermates (p.
chain +1—), which have normal humoral immunity and develop
normal antibody response to the disease initiating antigen.
Methods
Mice
p. chain deficient mice were originally generated by Prof.
Rajewsky [41 from 129/Sv derived embryonic stem cells injected
into C57BL16 blastocysts. These mice were back crossed into the
C57BL16 strain for 8 generations by Dr. D. Tarlinton, Walter and
Eliza Flail Institute of Medical Research, Parkville, Victoria,
Australia. Their phenotypes were confirmed by flow cytometric
analysis of B220 (CD45R) and surface immunoglobulin on circu-
lating B cells.
Induction of anti-GBM GN
Anti-GBM globulin was prepared from serum of a sheep
immunized against a particulate fraction of mouse GBM by
absorption with mouse red blood cells and ammonium sulphate
precipitation, as previously described [6, 7]. Mice, between 8 and
14 weeks of age, were sensitized to sheep globulin by s.c. injection
of a total of 2 mg in 100 p.1 of CFA (Sigma Chemical Co., St.
Louis, MO, USA) in divided doses in each flank. Fourteen days
later, GN was initiated by iv. administration of 7.5 mg of sheep
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anti-mouse GBM globulin. This dose did not induce acute (het-
erologous phase) proteinuria or histological injury in nonimmu-
nized mice. Histological indices of glomerular injury were as-
sessed 14 days after administration of anti-GBM globulin and
proteinuria and DTH over the preceeding 24 hours.
Histological assessment of glomerular injury
Glomerular crescent foimation. Kidney tissue was fixed in
Bouin's fixative, embedded in paraffin and 3 p.m tissue sections
were cut and stained with Periodic acid-Schiff (PAS) reagent.
Glomerular crescent formation was assessed by an experienced
histopathologist (PGT) in a blinded protocol. Glomeruli were
considered to exhibit crescent formation when more than three
layers of cells were observed in Bowman's space. A minimum of
20 glomeruli were assessed to determine the crescent score for
each animal.
Functional assessment of glomerular injury
Proteinuria. Mice were housed individually in cages to collect
urine over the final 24 hours of each experiment. Urinary protein
concentrations were determined by a modified Bradford method,
adapted to a microtiter plate assay as previously described [8].
The 24-hour urinary protein excretion was calculated from the
24-hour urine volume and the urinary protein concentration.
Serum creatinine and creatinine clearance. Serum and urine
creatinine concentrations were measured by the alkaline picric
acid method using an autoanalyzer (Cobas Bio; Roche Diagnostic,
Basel, Switzerland). Creatinine clearance was calculated from the
creatinine concentrations and the urine volume.
Assessment of immunological effectors in glomenili
Glomerular T cell and macrophage accumulation. Spleen and
kidney tissue was fixed in periodate lysine paraformaldehyde
(PLP) for four hours, washed in 7% sucrose solution then frozen
in liquid nitrogen cooled isopentane. Tissue sections (3 p.m) were
stained to demonstrate macrophages and T cells using a three
layer immunoperoxidase technique, as previously described [3, 7].
The primary antibodies were GK1.5 (monoclonal anti-mouse
CD4; ATCC, Rockville, MD, USA) and M1/70 (monoclonal
anti-mouse Mac-i, ATCC). Sections of spleen provided a positive
control for each animal and irrelevant rat monoclonal antibody
was substituted for primary monoclonal antibody to provide a
negative control. A minimum of 20 equatorially sectioned glomer-
uli per animal were assessed per animal and the results were
expressed as cells per glomerular cross section (c/gcs).
Iminunoglohulin and fibrin. Tissue sections (3 p.m) were cut
from snap frozen kidney and stained by direct immunofluores-
cence with FITC-conjugated sheep anti-mouse immunoglobulin
(Silenus, hawthorn, Victoria, Australia) and FITC conjugated
goat anti-mouse hhrinogen (Nordic, Drawer, CA, USA). Semi-
quantitative assessment of the glomerular deposition of these
inflammatory mediators was performed by determining the end
point positive titer for detection of staining of these antigens using
serial dilutions of each antibody.
Assessment of the systemic immune response
Circulating mouse anti-sheep globulin antibody. Titers of mouse
anti-sheep globulin antibody were measured by ELISA on serum
collected at the end of each experiment. Polystyrene inicrotiter
plates (Greiner Labortechnik, Germany) were coated with 5
p.g/ml normal sheep globulin in carbonate/bicarbonate buffer pFl
9.5 by incubation overnight at 4°C, and then blocked with 1%
BSA. Plates were washed with PBS containing 0.05% Tween 20,
then incubated with serial dilutions of mouse serum. After further
washing, bound mouse immunoglobulin was detected with horse
radish peroxidase conjugated rabbit anti-mouse immunoglobulin
antibody (Sigma) at a dilution of 1 in 1000 using 0.1 M 2,2'-azino-
di-3-ethylbenzthiazoline suiphonate (ABTS, Boehringer Mann-
heim, Germany) in 0.02% H202 as a substrate. The absorbance at
405 nm was read on a microtiter plate reader (Dynatech Labora-
tories, Chantihly, VA, USA). Serum from each mouse was tested
at serial 1 in 4 dilutions, starting from a dilution of 1 in 50 in each
group except for serum from wild-type C57BL/6 mice, which was
titered from a starting dilution of 1 in 100.
Delayed type hypersensitivity to sheep globulin. Mice were chal-
lenged 24 hours prior to the end of each experiment by intrader-
mal injection of sheep globulin (20 sg in 20 p.1 of PBS) into the
plantar surface of a hind foot. An irrelevant antigen (horse
globulin) was injected in the opposite foot pad as a control. DTH
was assessed 24 hours later by determining the presence or
absence of footpad swelling in a blinded protocol.
T helper cell depletion protocol
T helper cell depletion was induced by i.p. injection of 0.5 mg
per mouse of protein G purified rat anti-mouse CD4 monoclonal
antibody (GK 1.5), administered daily for four days, starting 24
hours before injection of anti-GBM globulin. A further dose of 0.5
mg was given on the seventh day after anti-GBM globulin. This
antibody has been previously established to produce prolonged T
helper cell depletion in vivo [9, 10]. The extent of T cell depletion
in the blood and spleen (using isolated spleen cells) on day 14
after administration of anti-GBM globulin was assessed by flow
cytometry by dual labeling with anti-CD3 (29B, Sigma) and
anti-CD4 (KT6; Serotec, Oxford, UK) or anti-CD8 (53-6.7;
Sigma) antibodies.
Experimental design and statistical analysis
The following groups were studied:
(1.) Normal C57BL/6 mice (N = 6);
(2.) Normal heterozygous p. chain deficient mice (p. chain +/—)
(N=4);
(3.) Normal homozygous p. chain deficient mice (p. chain —/--)
(N=4);
(4.) Heterozygous p. chain deficient mice (p. chain +/—) with
anti-GBM GN (N 5);
(6,) T cell depleted, heterozygous p. chain deficient mice (p. chain
+1—) with anti-GBM GN (N = 6);
(7.) Homozygous p. chain deficient mice (p. chain —/—) with
anti-GBM GN (N = 8).
The statistical significance of differences between groups was
determined by the Mann Whitney U-test.
Results
Renal function and immune response to sheep globulin in wild-
type and p. chain deficient mice
Normal wild-type, heterozygous and homozygous p. chain defi-
cient mice showed no differences in their 24-hour urinary protein
674 Li et al: Antibody independent crescentic glomerulonephitis
Serum creatinine
pM/liter
Proteinuria
mg/24 h
Wild-type 10 1.5 1.6 0.2
js Chain +7— 8.5 1.3 1.4 0.4
jr Chain —7-- 10 1.8 1.9 0.2
excretion and serum creatinines (Table 1) and their kidneys were
all histologically normal.
Heterozygous and wild-type mice showed identical cell surface
expression of B220 (CD45R) on circulating lymphocytes by flow
cytometry indicating the presence of similar numbers of mature B
cells (Fig. 1). Their serum titers of anti-sheep globulin antibody
after immunization according to the protocol for inducing anti-
GBM GN were also identical (Fig. 2). In homozygous ( chain
—/—) chain deficient mice, B220 expression on circulating
lymphoctyes was not detectable above background levels, indicat-
ing an absence of mature B cells (Fig. 1), and anti-sheep globulin
was undetectable in their serum after immunization (Fig. 2).
Immunized wild-type, heterozygous and homozygous p. chain
deficient mice developed cutaneous delayed type hypersensitivity
following challenge with sheep globulin. Pronounced swelling
occurred at the site of challenge and T cells and macrophages
accumulation was prominent histologically. Challenge with horse
globulin in the opposite footpad did not induce skin swelling.
Development of anti-GBM GN in heterozygous
p. chain deficient mice
Heterozygous (p. chain +1—) p. chain deficient mice developed
a proliferative crescentic GN (Fig. 3A) the same as that previously
reported in wild-type C57BL/6 mice using this protocol [11].
Crescents were observed 33.1 2.4% of glomeruli in p. chain +1—
mice with anti-GBM GN (Fig. 4), but were not observed in normal
mice. This crescentic GN was associated with a significant glomer-
ular accumulation of CD4 positive T cells (0.92 0.08 c/gcs,
normal 0.01 0,01 c/gcs, P < 0.001) and macrophages (1.47
0.19 c/gcs, normal 0.01 0.001 c/gcs, P < 0.001; Fig. 4) and
prominent glomerular fibrin deposition. Deposition of mouse
immunoglobulin in a linear pattern was detectable in glomeruli
(Fig. 3D) at a mean end point titer of I in 4000 of sheep
anti-mouse immunoglobulin FITC.
Heterozygous mice with anti-GBM GN developed significant
protcinuria (6.4 1.4 mg/24 hr, P < 0.05) compared with normal
p. chain +/— (1.4 0.3 mg/24 hr; Fig. 5) and wild-type C57BL/6
mice of a similar age (0.9 0.2 mg/24 hr). The serum creatinine
was also significantly increased (32.6 3.3 p.M/liter, P < 0.05)
compared to normal p. chain +1— (8.5.± 1.8 p.M/liter) and
wild-type C57B1/6 (10.0 1.8 p.M/liter) mice and the creatinine
clearance (90.0 13.4 p1/mm) was also significantly reduced
compared with normal C57BI/6 mice (193 10.4 p.1/mm, P =
0.02; Fig. 5).
-
Fig. 1. Flow cytometric analysir of B220 (CD45R) expression on blood
leukocytes from (A) a normal C57BL/6 (wild-type) mouse, (B) heterozygous
p. chain deficient (p. +/—) mouse, and (C) a homozygous p. chain deficient
(p. —I—) mouse demonstrating equivalent B220 antigen expression in the
wild-type and heterozygotes, hut no significant expression above background
(to the left of the broken line) in the homozygous p. chain deficient mouse.
Table 1. Normal renal function in C57BL/6 (wild type), heterozygous
(p. chain +7—) and homozygous (p. chain —I--) deficient mice A
lIIl
Log (fluorescence intensity)
B
0
Q)
-0
E
C!)
Log (fluorescence intensity)
C
1LII
Log (fluorescence intensity)
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2
1.8
1.6
1.4
1.2
1
d 0.80
0.6
0.4
0.2
0
Fig. 2. Serum titers of mouse anti-sheep globulin antibody in wild-type (0),
heterozygote (.r +/—) .r chain deficient •)' T cell depleted heterozygote p.
chain deficient (X) and homozygous p. chain deficient (p.—/—) mice on day
14 of anti-GBM GN. Optical density (OD) of wells with serum from
homozygotes p. chain deficient (p. +1—) mice (•) was below background
(1% BSAJPBS control) indicated by the shaded area.
In vivo treatment with anti-CD4 antibody produced a significant
depletion of CD4 bearing cells in the blood and spleen. In treated
mice on day 14, CD3/CD4 positive cells were reduced to 1.45
0.22% of total circulating leukocytes (normal 17.7%), whereas
CD3/CD8 positive cells (14.3 1.4%) were unaffected (normal
16.5%). A similar effect was observed in the spleen, with CD3I
CD4 positive cells reduced to 0.6 0.05% of total splenocytes
(normal 18.1%) and CD3ICD8 positive cells (12.0 1.5%)
unaffected (normal 12.1%).
T cell depletion significantly attenuated the development of
disease in p. chain +1— mice. Crescent formation was significantly
attenuated (1.6 0.8% of glomeruli, P = 0.006) in T cell depleted
heterozygous mice, as was glomerular accumulation of CD 4
positive T cells (0.30 0.10 c/gcs, P = 0.011) and macrophages
(0.64 0.13 c/gcs, P = 0.019), compared to untreated disease in
heterozygotes. Proteinuria (2.7 0.2 mg/24 hr, P = 0.075) and
serum creatinine (19.5 2.6 p.M/liter, P = 0.028) were also
reduced compared to untreated heterozygous mice with anti-
GBM GN (Fig. 5). Creatinine clearance in T cell depleted mice
(193 10.4 p.1/mm, P = 0.02) was significantly higher than in
untreated mice. The glomerular deposition of mouse immuno-
globulin as assessed by immunofluorescence appeared slightly
reduced in T cell depleted mice, the mean end point titer of sheep
anti-mouse immunoglobulin antibody- FITC for detection was 1 in
2000 compared with 1 in 4000 in untreated heterozygous mice.
Circulating titers of mouse anti-sheep globulin were unaffected by
T cell depletion (Fig. 2).
Development of anti-GBM G1'J in homozygous
p. chain deficient mice
Homozygous (p. chain —I—) p.chain deficient mice developed a
proliferative crescentic GN of similar severity to heterozygous
mice (Fig. 3A). Crescent formation (28.9 2.2% of glomeruli),
glomerular accumulation of CD4 positive T cells (1.01 0.17
c/gcs) and macrophages (1.60 0.23 c/gcs) was not significantly
different from heterozygous mice (Fig. 4). Fibrin deposition in
glomeruli was also present to a similar extent, however, mouse
immunoglobulin was totally undetectable in glomeruli of p. chain
—I— mice (Fig. 3C). The extent of proteinuria (3.8 1.0 mg/24
hr), the elevation of serum creatinine (24.5 3.4 p.M/liter) and
reduced creatinine clearance (135 29.0 p.1/mm) in homozygous
p. chain deficient mice were not significantly different from
heterozygous mice with anti-GBM GN (Fig. 5).
Discussion
Early studies of the immunological events in GN emphasized
the role of antibody and complement as effectors of injury [12—16]
and resulted in the potential involvement of T cells being largely
discounted [17, 18]. However, the observation that many patients
develop crescentic GN in the absence of detectable immunoglob-
ulin deposition in their glomeruli [1] renewed interest in the
possibility that cell mediated immunity may play an important role
in crescentic forms of GN.
Several studies have addressed this hypothesis in the past.
Kreisburg, Wayne and Karnovsky demonstrated glomerular local-
ization of lymphocytes during the onset of anti-GBM GN in rats
[19]. Bhan produced histological evidence of glomerular injury
after passive transfer of sensitized T cells to rats with planted
antigens and immune-complexes in their glomeruli [20, 21].
Athymic (nude) mice [221 do not develop humoral or cellular
immune responses and fail to develop autologous injury following
anti-GBM serum. Athymic rats are also protected from autolo-
gous phase anti-GBM GN and develop proteinuria but not
crescents following passive transfer of autologous antibody [23].
Effectors of delayed type hypersensitivity have been demonstrated
in association of with crescentic GN in humans [2] and strategies
have been devised to selectively block either the humoral [24] or
cellular effector arm [3] of the immune system in experimental
models of GN.
Other evidence supporting the potential of T cells to cause
glomerular injury comes from studies in which haptens have been
selectively planted in the kidney to induce a predominant T cell
dependent immune response. [25, 26]. Oite et al perfused sensi-
tized rats with trinitrobenzene sulphonic acid (TNP) coupled to
BSA via the renal artery and induced a marked proliferative GN
and transient proteinuria, associated with accumulation of Ta
positive cells in glomeruli, in the absence of detectable immuno-
globulin and complement [25]. Sensitized rats developed low
circulating antibody titers to TNP demonstrating the difficulty in
completely preventing a humoral immune response. Rennke et al
[26] adopted a similar approach by infusing azobenzenearsonate
into the kidneys of sensitized rats. This resulted in a granuloma-
tous cortical inflammatory response with glomerular hypercellu-
larity and crescents, but no abnormal proteinuria. Systemic trans-
fer of sensitized T cells resulted in a similar histological lesion,
albeit somewhat attenuated in severity. A diffuse inflammatory
infiltrate of macrophages and T cells was present throughout the
kidney and despite the presence of circulating antibody to azo-
benzenearsonate, minimal rat immunoglobulin and complement
was detected in glomeruli.
The development of mice with specific genetic deletion of
selective parts of the immune effector system now allows the role
of the antibody and T cells in crescentic GN to be addressed more
definitively. Mice with disruption of one of the membrane exons
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Fig. 3. Photomicrographs of glomeruli from homozygous (A and C) and heterozygous (B and D) t chain deficient mice with anti-GBM GN demonstrating
an identical prolferative and crescentic GN in both mice (A and B, PAS stain, magnification )<400), with undetectable mouse immunoglobulin in the
homozygous mouse (C) and strong linear deposition in the heterozygous mouse (both immunofluorescence, magnification X400).
of the gene encoding for the it-chain constant region of the 1gM
heavy chain were produced by gene targeting in mouse embryonic
stem cells [4]. Heterozygous expression of this defect did not
result in any phenotypic abnormalities, however, homozygous
mice demonstrated arrest of B cell development at an immature
pre-B stage and an absence of mature B cells (identified by
surface expression of B220 antigen [27]). These mice have no
circulating or surface immunoglobulin [4] and fail to develop
antibody responses following antigen challenge. However, they
demonstrate normal T cell priming and effector responses to
antigens both in vitro and in vivo [5], and thus provided an ideal
system in which to address the requirement for antibody in the
development of crescentic GN.
GN was induced by planting an antigen (sheep globulin) on the
glomerular basement membrane of mice previously sensitized to
this antigen. GN results from an active immune response to this
exogenous planted antigen in a similar manner to many of forms
of human GN, in which antigens exogenous to the kidney (often
bacterial or parasitic) become lodged in the glomerulus and an
antigen specific immune response results in local glomerular
injury. In this model, there is no loss of tolerance to GBM
antigens as occurs in human anti-GBM disease and in experimen-
tal GN induced rats [28] and rabbits [29] by immunization with the
a3 chain of the noncollagenous domain of type IV collagen.
However, the pathological features of GN (severe renal impair-
ment, proteiniuria, prominent crescent formation, glomerular
fibrin deposition and accumulation of CD4 positive T cells,
macrophages) closely parallel the features of human anti-GBM
GN and other types of rapidly progressive erescentic GN.
In heterozygous chain deficient mice, this induced a crescen-
tic GN, characterized by glomerular deposition of autologous
(mouse anti-sheep globulin) antibody and accumulation of CD4
positive T cells and macrophages in glomeruli and results in
proteinuria and renal impairment. Glomerular T cell and macro-
phage recruitment, crescent formation and injury were signifi-
cantly attenuated by in vivo depletion of CD4 positive T cells,
demonstrating that this form of injury is T cell dependent in the
effector phase. In the T cell depletion protocol employed in this
study, no effect was seen on circulating autologous antibody
measured by ELISA, but a minor reduction of glomcrular depo-
sition of autologous antibody was suggested by immunofluores-
cence, As complete absence of glomerular deposition of autolo-
gous antibody in homozygous ji-chain deficient mice did not
significantly alter the development of disease, it is unlikely that
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Fig. 4. (A) Glomerular crescent scores (% of glomeruli demonstrating
crescents) and (B) glomerular T cell and (C) macrophage accumulation
(cells per glomerular cross-section) in homozygous (r chain —I--) deficient
mice with anti-GBM GN, non-diseased (normal) heterozygous (z chain
+1—) deficient mice and intact and T cell depleted heterozygous mice with
antiGBM GN.
t chain -I-t chain ÷I mice mice
Fig. 5. (A) Serum creatinine (p.M/liter), (B) creatinine clearance (p1/mm)
and (C) proteinuria (mg/24 hr) in homozygous (p. chain —I—) deficient
mice with anti-GBM GN, non-diseased (normal) heterozygous (p. chain
+1—) deficient mice and intact and T cell depleted heterozygous mice with
anti-GBM GN.
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this minor effect of T depletion contributed to its profound effects
on development of crescentic GN.
In homozygous p.-chain deficient mice, despite complete ab-
sence of circulating and glomerular mouse immunoglobulin,
crescent formation, proteinuria and renal impairment was essen-
tially the same as in B cell intact mice. These mice also demon-
strated cutaneous DTH following challenge with the GN initiating
antigen and glomerular accumulation of T cells and macrophages
was unaffected. The immunopathological features of disease in
these mice are thus similar to those seen in pauci-immune
crescentic human GN, although there is no evidence of systemic
vasculitis that often accompanies ANCA associated GN.
These studies clearly demonstrate that glomerular antibody
deposition is not required for crescent formation in response to a
planted glomerular antigen. This is consistent with the previous
study of Bolton, Tucker and Sturgill, who induced a model of
proliferative GN by immunization of chickens with bovine gb-
merular basement membrane [241. These birds developed primi-
tive crescents in association with glomerular accumulation of
esterase positive macrophages and subsequently these authors
demonstrated that disease could be transferred passively by
administration of mononuclear cells from the spleen and kidneys
from nephritic birds. Bursectomy using cyclophosphamide re-
sulted in very low or undetectable anti-GBM antibody titers, and
appeared to exacerbate the development of proliferative GN and
crescents. While bursectomy in birds allowed dissection of T and
B cell effector mechanisms, substantial difference between avian
and mammalian renal morphology, physiology and pathology
diminish the relevance of these studies to human disease. The
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mouse model employed in the current studies has similar immu-
nopathological and functional outcomes to those seen in human
crescentic GN. Antibody depletion was absolute and the involve-
ment of T cells in the glomerular lesion was demonstrated both
histologically and functionally.
A second approach to demonstrating the contribution of the
cellular and humoral effector arms of the immune system to
development of crescentic GN has been by attempting to selec-
tively block the T cells in vivo [3]. The results of these studies also
support a pivotal effector role for T helper cells by demonstrating
that depletion of either CD4 or CD5 positive T cells in rats with
an established antibody response prevented development of cres-
cents and injury in response to a planted glomerular antigen. This
attenuation of disease was not associated with detectable reduc-
tion of the humoral immune response [3]. The development of
crescents in association with T cell and macrophage recruitment
and fibrin deposition in glomeruli suggests that crescent formation
is an manifestation of DTH-like glomerular injury.
In summary, the current studies demonstrate that glomerular
crescents can develop as a result of a T cell dependent immune
response to a planted glomerular antigen. They provide a clear
demonstration of the pivotal role for cell mediated immunity in
the development of crescentic GN in the total absence of any
participation of antibody.
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